These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18035558)

  • 41. Amyloid-β and τ biomarkers in Parkinson's disease-dementia.
    Buongiorno M; Compta Y; Martí MJ
    J Neurol Sci; 2011 Nov; 310(1-2):25-30. PubMed ID: 21764078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.
    Bertrand E; Lechowicz W; Szpak GM; Lewandowska E; Dymecki J; Wierzba-Bobrowicz T
    Folia Neuropathol; 2004; 42(3):141-50. PubMed ID: 15535032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.
    Fan Z; Aman Y; Ahmed I; Chetelat G; Landeau B; Ray Chaudhuri K; Brooks DJ; Edison P
    Alzheimers Dement; 2015 Jun; 11(6):608-21.e7. PubMed ID: 25239737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.
    Ng SY; Villemagne VL; Masters CL; Rowe CC
    Arch Neurol; 2007 Aug; 64(8):1140-4. PubMed ID: 17698704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia.
    Edison P; Ahmed I; Fan Z; Hinz R; Gelosa G; Ray Chaudhuri K; Walker Z; Turkheimer FE; Brooks DJ
    Neuropsychopharmacology; 2013 May; 38(6):938-49. PubMed ID: 23303049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
    Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P
    Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tau protein, beta-amyloid₁₋₄₂ and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia.
    Vranová HP; Hényková E; Kaiserová M; Menšíková K; Vaštík M; Mareš J; Hluštík P; Zapletalová J; Strnad M; Stejskal D; Kaňovský P
    J Neurol Sci; 2014 Aug; 343(1-2):120-4. PubMed ID: 24928081
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amyloid PET Imaging in Lewy body disorders.
    Donaghy P; Thomas AJ; O'Brien JT
    Am J Geriatr Psychiatry; 2015 Jan; 23(1):23-37. PubMed ID: 23831180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical features of Pittsburgh compound-B-negative dementia.
    Takeuchi J; Shimada H; Ataka S; Kawabe J; Mori H; Mizuno K; Wada Y; Shiomi S; Watanabe Y; Miki T
    Dement Geriatr Cogn Disord; 2012; 34(2):112-20. PubMed ID: 22947919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease.
    Janvin CC; Larsen JP; Salmon DP; Galasko D; Hugdahl K; Aarsland D
    Mov Disord; 2006 Mar; 21(3):337-42. PubMed ID: 16211595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case-control study.
    Ances BM; Christensen JJ; Teshome M; Taylor J; Xiong C; Aldea P; Fagan AM; Holtzman DM; Morris JC; Mintun MA; Clifford DB
    Neurology; 2010 Jul; 75(2):111-5. PubMed ID: 20534887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia.
    Cormack F; Aarsland D; Ballard C; Tovée MJ
    Int J Geriatr Psychiatry; 2004 Apr; 19(4):371-7. PubMed ID: 15065231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies.
    Mosimann UP; Müri RM; Burn DJ; Felblinger J; O'Brien JT; McKeith IG
    Brain; 2005 Jun; 128(Pt 6):1267-76. PubMed ID: 15774501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
    Fodero-Tavoletti MT; Mulligan RS; Okamura N; Furumoto S; Rowe CC; Kudo Y; Masters CL; Cappai R; Yanai K; Villemagne VL
    Eur J Pharmacol; 2009 Sep; 617(1-3):54-8. PubMed ID: 19576880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
    Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced Synaptic Density in Patients with Lewy Body Dementia: An [
    Andersen KB; Hansen AK; Damholdt MF; Horsager J; Skjaerbaek C; Gottrup H; Klit H; Schacht AC; Danielsen EH; Brooks DJ; Borghammer P
    Mov Disord; 2021 Sep; 36(9):2057-2065. PubMed ID: 33899255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction between α-synuclein and tau in Parkinson's disease comment on Wills et al.: elevated tauopathy and α-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol 2010; 225: 210-218.
    Jellinger KA
    Exp Neurol; 2011 Jan; 227(1):13-8. PubMed ID: 20965169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
    Tsuboi Y; Uchikado H; Dickson DW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients.
    Forsberg A; Juréus A; Cselényi Z; Eriksdotter M; Freund-Levi Y; Jeppsson F; Swahn BM; Sandell J; Julin P; Schou M; Andersson J; Johnström P; Varnäs K; Halldin C; Farde L; Svensson S
    Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):580-93. PubMed ID: 23324871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Negative 11C-PIB PET Predicts Lack of Alzheimer's Disease Pathology in Postmortem Examination.
    Scheinin NM; Gardberg M; Röyttä M; Rinne JO
    J Alzheimers Dis; 2018; 63(1):79-85. PubMed ID: 29614642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.